Please read it carefully as it may affect your legal rights. TORONTO and MONTREAL, Nov. 12, 2024 /CNW/ - A proposed Settlement has been reached on behalf of all individuals in Canada who were ...

Two companies that have been blazing a trail in this field are Otsuka Pharmaceutical Company and Proteus Digital Health, with the co-developed Abilify MyCite (aripiprazole tablets with sensor ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

The use and ethics of antipsychotic drugs in nursing homes is an ongoing discussion. Learn why these medications are ...

Alcohol can change how your body breaks down and absorbs medications, causing adverse reactions, and even overdose. Here are ...

H. Lundbeck AS (HLUBF) reports robust financial results with significant growth in strategic brands and a positive outlook for the year.

Accelerated growth for strategic brands (+21% CER) drives revenue up 13% CER in the first nine months of 2024 Key highlights Lundbeck's total revenue grew by +13% CER[1] (+10% DKK) to DKK 16,463 milli ...

Reporting to Chief Financial Officer Frank Dunsford, Kelley will lead the company's financial strategy, overseeing... at 10:58 Proposed Settlement Reached in the Canadian ABILIFY® and ABILIFY ...

Together with Japan's Otsuka Pharmaceuticals, the company produced the ground-breaking smart pill Abilify Mycite (aripiprazole). But the partnership ran into trouble after poor uptake by payers in ...

Reporting to Chief Financial Officer Frank Dunsford, Kelley will lead the company's financial strategy, overseeing... at 10:58 Proposed Settlement Reached in the Canadian ABILIFY® and ABILIFY ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can ...

Bristol-Myers Squibb Company ( NYSE: BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference November 11, 2024 10:00 AM ET Samit Hirawat - EVP, Chief Medical Officer, Global Drug ...